1293 related articles for article (PubMed ID: 8597625)
1. Antigen-specific primary immune response of human B-lymphocytes after in vitro immunization with GM3 ganglioside.
Alfonso M; Lanne B; Ifversen P; Vázquez AM; Pérez R; Portoukalian J; Zeuthen J
Hum Antibodies Hybridomas; 1995; 6(3):102-12. PubMed ID: 8597625
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning of a human monoclonal antibody reactive to ganglioside GM3 antigen on human cancers.
Hoon DS; Wang Y; Sze L; Kanda H; Watanabe T; Morrison SL; Morton DL; Irie RF
Cancer Res; 1993 Nov; 53(21):5244-50. PubMed ID: 7916649
[TBL] [Abstract][Full Text] [Related]
3. Mimicking the humoral immune response in vitro results in antigen-specific isotype switching supported by specific autologous T helper cells: generation of human HIV-1-neutralizing IgG monoclonal antibodies from naive donors.
Chin LT; Malmborg AC; Kristensson K; Hinkula J; Wahren B; Borrebaeck CA
Eur J Immunol; 1995 Mar; 25(3):657-63. PubMed ID: 7535699
[TBL] [Abstract][Full Text] [Related]
4. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
5. [GM3 ganglioside as melanoma specific antigen and its biological function].
Hirabayashi Y; Taniguchi M
Hum Cell; 1989 Mar; 2(1):63-9. PubMed ID: 2535260
[TBL] [Abstract][Full Text] [Related]
6. Generation of human monoclonal antibodies against ganglioside antigens and their applications in the diagnosis and therapy of cancer.
Alfonso M; Zeuthen J
Acta Oncol; 1996; 35(3):287-95. PubMed ID: 8679258
[TBL] [Abstract][Full Text] [Related]
7. In vitro immunization of human B lymphocytes with cultured melanoma cells (SK-MEL 28).
Zhang XM; Borrebaeck CA
Hum Antibodies Hybridomas; 1990; 1(1):42-6. PubMed ID: 1966473
[TBL] [Abstract][Full Text] [Related]
8. Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen.
Nores GA; Dohi T; Taniguchi M; Hakomori S
J Immunol; 1987 Nov; 139(9):3171-6. PubMed ID: 3668254
[TBL] [Abstract][Full Text] [Related]
9. An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo.
Dohi T; Nores G; Hakomori S
Cancer Res; 1988 Oct; 48(20):5680-5. PubMed ID: 3167827
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanoma.
Azuma Y; Ishikawa Y; Kawai S; Tsunenari T; Tsunoda H; Igawa T; Iida S; Nanami M; Suzuki M; Irie RF; Tsuchiya M; Yamada-Okabe H
Clin Cancer Res; 2007 May; 13(9):2745-50. PubMed ID: 17473208
[TBL] [Abstract][Full Text] [Related]
11. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
[TBL] [Abstract][Full Text] [Related]
12. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
13. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
14. Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3.
Yamamoto S; Yamamoto T; Saxton RE; Hoon DS; Irie RF
J Natl Cancer Inst; 1990 Nov; 82(22):1757-60. PubMed ID: 1700134
[TBL] [Abstract][Full Text] [Related]
15. Development of a human monoclonal antibody to ganglioside G(M2) with potential for cancer treatment.
Nishinaka Y; Ravindranath MH; Irie RF
Cancer Res; 1996 Dec; 56(24):5666-71. PubMed ID: 8971173
[TBL] [Abstract][Full Text] [Related]
16. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
17. Gangliosides, Ab1 and Ab2 antibodies III. The idiotype of anti-ganglioside mAb P3 is immunogenic in a T cell-dependent manner.
López-Requena A; Bestagno M; Mateo de Acosta C; Cesco-Gaspere M; Vázquez AM; Pérez R; Burrone OR
Mol Immunol; 2007 Apr; 44(11):2915-22. PubMed ID: 17316805
[TBL] [Abstract][Full Text] [Related]
18. Human monoclonal antibodies to viral peptides.
Sidorova E; Borisova T; Lyakisheva L; Rosen A
Hum Antibodies; 1997; 8(2):65-9. PubMed ID: 9289390
[TBL] [Abstract][Full Text] [Related]
19. Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function.
de León J; Fernández A; Clavell M; Labrada M; Bebelagua Y; Mesa C; Fernández LE
Int Immunol; 2008 Apr; 20(4):591-600. PubMed ID: 18310617
[TBL] [Abstract][Full Text] [Related]
20. Role of cell surface GM3 ganglioside and sialic acid in the antitumor activity of a GM3-based vaccine in the murine B16 melanoma model.
Gabri MR; Ripoll GV; Alonso DF; Gómez DE
J Cancer Res Clin Oncol; 2002 Dec; 128(12):669-77. PubMed ID: 12474053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
